Wednesday, June 15, 2011

Ethical Drug Shortage? Guess What Causes That!

Teh Won's Ideal State approaches.

Doctors at the Johns Hopkins cancer center are rationing cytarabine, a drug used to treat leukemia and lymphoma. They are literally deciding who will live and who will die. The drug is also in short supply at the Stanford, Wisconsin and Nebraska university medical centers.

...Currently, there are about 246 drugs that are in short supply and as the chart shows, the number has been growing for some time. There were 74 newly reported drug shortages in 2005; the number dipped slightly to 70 in 2006, then rose to 129 in 2007, 149 in 2008, 166 in 2009, and 211 in 2010

...A new report from the Premier healthcare alliance that found that drug shortages have risen to “critical levels,” endangering the public’s health. Hospitals are scrambling to make up the shortfall, in some cases rationing medications, postponing surgeries and using alternative drugs


The Federal Food and Drug Administration (FDA) has been stepping up its quality enforcement efforts — levying fines and forcing manufacturers to retool their facilities both here and abroad. Not only has this more rigorous regulatory oversight slowed down production, the FDA’s “zero tolerance” regime is forcing manufacturers to abide by rules that are rigid, inflexible and unforgiving.

Well, quality-control is good, right?

Not when The Bureaucrats are in charge:

For example, a drug manufacturer must get approval for how much of a drug it plans to produce, as well as the timeframe. If a shortage develops (because, say, the FDA shuts down a competitor’s plant), a drug manufacturer cannot increase its output of that drug without another round of approvals. Nor can it alter its timetable production (producing a shortage drug earlier than planned) without FDA approval.

F*&^ng IDIOTS.

HT: RenMan

1 comment:

Anonymous said...

Do you have problems with our LEADER’s Five-Year Plans for the National Economy of the (Soviet Union), err, I mean USA?